Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicine.

The group average API ratio (1.09) and the % difference of ipsilateral from contralateral (8.8) indicate a slight trend toward higher ipsilateral biopsy labeling but did not test significant across the cohort (Table 2 ; Fig. 2 ). 3.1.2.

also in 2,420 other papers